Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents.
Shah AS, Wilson DP.
2023 Feb 22. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Primary hypertriglyceridemia in children and adolescents.
Shah AS, Wilson DP.
J Clin Lipidol. 2015 Sep-Oct;9(5 Suppl):S20-8. doi: 10.1016/j.jacl.2015.04.004. Epub 2015 Apr 25.
Tuberoeruptive xanthomas: unusual presentation of type V hyperlipoproteinemia.
Norman RA, Genest J Jr.
Cutis. 1989 Feb;43(2):169-71.
Eruptive Xanthoma With Dermal Mucin Deposition.
Kim SM, Lee H, Kim YC.
Am J Dermatopathol. 2021 Aug 1;43(8):583-584. doi: 10.1097/DAD.0000000000001863.
Severe Combined Dyslipidemia With a Complex Genetic Basis.
Le R, Abbas M, McIntyre AD, Hegele RA.
J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619877050. doi: 10.1177/2324709619877050.
Liver transplantation in a patient with sitosterolemia and cirrhosis.
Miettinen TA, Klett EL, Gylling H, Isoniemi H, Patel SB.
Gastroenterology. 2006 Feb;130(2):542-7. doi: 10.1053/j.gastro.2005.10.022.
Case Report: Management of a Patient With Chylomicronemia Syndrome During Pregnancy With Medical Nutrition Therapy.
Zahedi M, Asghari G, Mirmiran P, Hosseinpanah F.
Front Nutr. 2021 Mar 5;8:602938. doi: 10.3389/fnut.2021.602938. eCollection 2021.
ApoE deficiency: markedly decreased levels of cellular ApoE mRNA.
Anchors JM, Gregg RE, Law SW, Brewer HB Jr.
Biochem Biophys Res Commun. 1986 Jan 29;134(2):937-43. doi: 10.1016/s0006-291x(86)80510-1.
Paediatric type III dyslipidaemia: a case of vanishing hyperlipidaemia.
Sarwal G, Al-Sarraf A, Frohlich J.
BMJ Case Rep. 2012 Nov 1;2012:bcr2012007579. doi: 10.1136/bcr-2012-007579.
Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
Feussner G, Albanese M, Mann WA, Valencia A, Schuster H.
Eur J Clin Invest. 1996 Jan;26(1):13-23. doi: 10.1046/j.1365-2362.1996.83232.x.
